FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent possessing antilitogenic action. The use of the agent of lyophilised, homogenised, fresh-frozen swine kidneys, as an agent having antilitogenic action.
EFFECT: agent is effective for treating urolithiasis.
4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROCESS FOR PREPARATION OF A PEPTIDE AGENT WITH ANTILITHOGENIC EFFECT | 2017 |
|
RU2652339C1 |
| PHARMACOLOGICAL AGENT FOR URINARY STONE DISEASE TREATMENT | 2018 |
|
RU2679120C1 |
| METHOD OF PROTEOMIC CORRECTION OF OXALATE NEPHROLITHIASIS | 2019 |
|
RU2704022C1 |
| PHARMACOLOGICAL AGENT FOR THE TREATMENT OF URATE NEPHROPATHY | 2021 |
|
RU2760949C1 |
| REMEDY FOR THE TREATMENT OF URATE NEPHROLITHIASIS | 2021 |
|
RU2762139C1 |
| METHOD FOR PREDICTING URATE NEPHROLITHIASIS | 2021 |
|
RU2759237C1 |
| METHOD FOR PREDICTION OF URINARY STONE DISEASE | 2010 |
|
RU2451935C1 |
| PHYTOAGENT "NEFROLIT" FOR TREATMENT AND PROPHYLAXIS OF UROLITHIASIS DISEASE | 2002 |
|
RU2218170C1 |
| METHOD FOR REHABILITATION OF PATIENTS WITH RENAL DISEASE | 1999 |
|
RU2177324C2 |
| DIURETIC | 2009 |
|
RU2408367C1 |
